Ignite Creation Date:
2025-12-25 @ 2:46 AM
Ignite Modification Date:
2026-02-28 @ 12:38 PM
Study NCT ID:
NCT06517433
Status:
COMPLETED
Last Update Posted:
2024-07-24
First Post:
2024-07-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
First-in-Human Dose Escalation Study of XMT-1536 in Cancers Likely to Express NaPi2b
Sponsor:
Mersana Therapeutics
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
MER-XMT-1536-1 DES
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None